Series D Medical Companies

Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.

CSA Medical is a provider of innovative spray cryotherapy medical device solutions.

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Medical device company that aims to Prevent Aspiration Pneumonia, VAP and Acute Kidney Injury in critical care patients

Neptune Medical is a medical device company that develops endoscopic and surgical devices.

Moximed develops innovative therapies for patients with knee osteoarthritis.

leon-nanodrugs is a nanotechnology-based drug development company.

Scopio Labs provides digital cell morphology imaging and AI solutions for hematology microscopy and diagnostics.

Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.

Eko Health is a digital health company providing digital stethoscopes and an AI detection platform for diagnosing heart and lung diseases.

Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics.

InfoBionic is the leading Virtual Telemetry Platform with connected devices manufactured in the US

DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Augmedics is a provider of augmented reality (AR) surgical image guidance solutions.

Heartseed is a clinical- stage biotechnology firm that focuses on utilizing regenerative medicine to address heart disease.

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

Lunaphore is a life sciences company that is creating technologies to enable spatial biology in all laboratories.

iThera Medical focuses on the development of proprietary MSOT technology for use in preclinical and clinical applications.